rss
Ann Rheum Dis 2009;68:1638-1643 doi:10.1136/ard.2008.094664
  • Basic and translational research
  • Extended report

The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus

  1. P Kümpers1,
  2. S David1,
  3. M Haubitz1,
  4. J Hellpap1,
  5. R Horn2,
  6. V Bröcker3,
  7. M Schiffer1,
  8. H Haller1,
  9. T Witte4
  1. 1
    Department of Nephrology, Hanover Medical School, Hanover, Germany
  2. 2
    Department of Gastroenterology, Hepatology and Endocrinology, Hanover Medical School, Hanover, Germany
  3. 3
    Institute of Pathology, Hanover Medical School, Hanover, Germany
  4. 4
    Department of Immunology and Rheumatology, Hanover Medical School, Hanover, Germany
  1. Correspondence to P Kümpers, Department of Nephrology, Hanover Medical School, Carl Neuberg Strasse 1, 30625 Hanover, Germany; kuempers.philipp{at}mh-hannover.de
  • Accepted 29 September 2008
  • Published Online First 17 October 2008

Abstract

Objective: To investigate the role of the angiopoietin–tyrosine kinase with Ig-like and epidermal growth factor-like domains (Ang–Tie) system in systemic lupus erythematosus (SLE). Endothelial activation is emerging as a key event for leukocyte recruitment and accelerated atherosclerosis in SLE. Recently, the endothelial-specific Ang–Tie ligand–receptor system has been identified as a major regulator of vascular responsiveness to inflammatory stimuli.

Methods: Ang1 (by immunoradiometric sandwich assay (IRMA)) and Ang2 (by ELISA) were measured in sera of 43 patients with SLE and 30 healthy controls. Expression of Ang2 was studied by immunohistochemistry in biopsies of human lupus nephritis.

Results: Circulating Ang2 concentrations were increased and concentrations of Ang1 decreased in patients with active SLE compared to healthy controls. This tendency was still present in inactive SLE, although less pronounced. Individual Ang2 concentrations correlated well with SLE Disease Activity Index (SLEDAI) score, proteinuria, double-stranded DNA (dsDNA) titre and soluble vascular cell adhesion molecule 1 (sVCAM-1). In a multivariate regression analysis, renal involvement was the only independent predictor for elevated Ang2. Serum Ang2 was identified as a strong predictor for disease activity by receiver operating characteristic (ROC) procedures and regression tree models. Protein expression of Ang2 was upregulated in glomeruli of patients with lupus nephritis.

Conclusions: These data indicate that Ang2-mediated disruption of protective Ang1/Tie2 signalling is operational in SLE. Ang2 might facilitate endothelial inflammation, permeability and contribute to premature atherosclerosis. Furthermore, circulating Ang2 may be a valuable new biomarker for disease activity in SLE. Strategies to control the deleterious effects of Ang2 may open new perspectives to prevent endothelial inflammation in SLE.

Footnotes

  • Competing interests None declared.

  • Ethics approval The study was performed in accordance with the declaration of Helsinki and approved by the institutional review board.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2008.094664v1
    2. 68/10/1638 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.